agilon health inc (NYSE:AGL)
agilon health inc
NYSE:AGL
EV/EBIT
Enterprise Value to EBIT
The Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
EV/EBIT
= Enterprise Value
/ EBIT
Current EV/EBIT
AGL
-20.7
Median EV/EBIT
AGL
N/A
Industry EV/EBIT
Health Care
14.2
EV/EBIT History
Statistics
Enterprise Value to EBIT
Enterprise Value to EBIT
| 1 Year | 3 Years | 5 Years | |
|---|---|---|---|
| Average | 26.6 | 9.3 | 5.7 |
| Median | 25.1 | N/A | N/A |
| Min | N/A | N/A | N/A |
| Max | 50.9 | 50.9 | 50.9 |
History Chart
Enterprise Value to EBIT
Enterprise Value to EBIT
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBIT
-173.4
2-Years Forward
EV/EBIT
197.3
3-Years Forward
EV/EBIT
59.6
EV/EBIT Across Competitors
AGL Competitors
agilon health inc Competitors
agilon health inc Competitors
Relative Valuation Report
View full relative valuation report for agilon health inc, which takes into account all AGL`s valuation multiples.
